Adipocyte-fatty acid binding protein and non-alcoholic fatty liver disease in the elderly

Aging Clinical and Experimental Research

Volumn 26, Issue 3, 2014, Pages 241-247

  Masetti, Marco ^a   Bianchi, Giampaolo ^a   Gianotti, Giordano ^a   Giovagnoli, Marco ^a   Vizioli, Luca ^a   Zorzi, Veronica ^a   Rossi, Valentina ^a   Forti, Paola ^a   Zoli, Marco ^a  

^a UNIVERSITY OF BOLOGNA   (Italy)

Author keywords

Metabolic syndrome; Metaflammation; Non alcoholic fatty liver disease

Indexed keywords

CHOLESTEROL; FATTY ACID BINDING PROTEIN 4; TRIACYLGLYCEROL; BIOLOGICAL MARKER; FABP4 PROTEIN, HUMAN; FATTY ACID BINDING PROTEIN; LIPID;

ADULT; AGED; AGING; ARTICLE; BODY FAT; CHOLESTEROL BLOOD LEVEL; CLINICAL EVALUATION; COHORT ANALYSIS; CROSS-SECTIONAL STUDY; DISEASE ASSOCIATION; ECHOGRAPHY; ERYTHROCYTE SEDIMENTATION RATE; FEMALE; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; MALE; NONALCOHOLIC FATTY LIVER; PROSPECTIVE STUDY; TRIACYLGLYCEROL BLOOD LEVEL; BLOOD; DIABETES MELLITUS; FATTY LIVER; METABOLIC SYNDROME X; PATHOLOGY;

AGED; AGING; BIOLOGICAL MARKERS; COHORT STUDIES; CROSS-SECTIONAL STUDIES; DIABETES MELLITUS; FATTY ACID-BINDING PROTEINS; FATTY LIVER; FEMALE; FOLLOW-UP STUDIES; HUMANS; LIPIDS; MALE; METABOLIC SYNDROME X;

EID: 84904650300     PISSN: 15940667     EISSN: 17208319     Source Type: Journal    
DOI: 10.1007/s40520-013-0156-0     Document Type: Article

References (30)

1. Furuhashi M, Ishimura S, Ota H et al (2011) Lipid chaperones and metabolic inflammation. Int J Inflam 2011:642612
2. Hotamisligil GS (2006) Inflammation and metabolic disorders. Nature Dic 444(7121):860-867
3. Baar RA, Dingfelder CS, Smith LA et al (2005) Investigation of in vivo fatty acid metabolism in AFABP/aP2(-/-) mice. Am J Physiol Endocrinol Metab Gen 288:E187-E193 (Pubitemid 40023806)
4. Elmasri H, Karaaslan C, Teper Y et al (2009) Fatty acid binding protein 4 is a target of VEGF and a regulator of cell proliferation in endothelial cells. FASEB J 23:3865-3873
5. Fu Y, Luo N, Lopes-Virella MF (2000) Oxidized LDL induces the expression of ALBP/aP2 mRNA and protein in human THP-1 macrophages. J Lipid Res Dic 41:2017-2023
6. Wang XQ, Yang K, He YS et al (2011) Receptor mediated elevation in FABP4 levels by advanced glycation end products induces cholesterol and triacylglycerol accumulation in THP-1 macrophages. Lipids 46:479-486
7. Fu Y, Luo N, Lopes-Virella MF et al (2002) The adipocyte lipid binding protein (ALBP/aP2) gene facilitates foam cell formation in human THP-1 macrophages. Atherosclerosis 165:259-269 (Pubitemid 35333352)
8. Makowski L, Brittingham KC, Reynolds JM et al (2005) The fatty acid-binding protein, aP2, coordinates macrophage cholesterol trafficking and inflammatory activity. Macrophage expression of aP2 impacts peroxisome proliferator-activated receptor gamma and Ikappa B kinase activities. J Biol Chem 280:12888-12895
9. Hui X, Li H, Zhou Z et al (2010) Adipocyte fatty acid-binding protein modulates inflammatory responses in macrophages through a positive feedback loop involving c-Jun NH2-terminal kinases and activator protein-1. J BiolChem 2(285):10273-10280
10. Stejskal D, Karpisek M (2006) Adipocyte fatty acid binding protein in a Caucasian population: a new marker of metabolic syndrome? Eur J Clin Invest 36:621-625 (Pubitemid 44213828)
11. Kim Y-C, Cho Y-K, Lee W-Y et al (2011) Serum adipocyte-specific fatty acid-binding protein is associated with nonalcoholic fatty liver disease in apparently healthy subjects. J Nutr Biochem 22:289-292
12. Tuncman G, Erbay E, Hom X et al (2006) A genetic variant at the fatty acid-binding protein aP2 locus reduces the risk for hypertriglyceridemia, type 2 diabetes, and cardiovascular disease. Proc Natl Acad Sci USA 103:6970-6975
13. Furuhashi M, Tuncman G, Görgün CZ et al (2007) Treatment of diabetes and atherosclerosis by inhibiting fatty-acid-binding protein aP2. Nature 447(7147):959-965 (Pubitemid 46975747)
14. Makowski L, Boord JB, Maeda K et al (2001) Lack of macrophage fatty-acid-binding protein aP2 protects mice deficient in apolipoprotein E against atherosclerosis. Nat Med 7:699-705 (Pubitemid 32588026)
15. Makowski L, Hotamisligil GS (2004) Fatty acid binding proteins-the evolutionary crossroads of inflammatory and metabolic responses. J Nutr 134:2464S-2468S (Pubitemid 39201622)
16. Byrne CD, Olufadi R, Bruce KD et al (2009) Metabolic disturbances in non-alcoholic fatty liver disease. Clin Sci 116:539-564
17. Bianchi G, Rossi V, Muscari A et al (2008) Physical activity is negatively associated with the metabolic syndrome in the elderly. QJM 101:713-721
18. Muscari A, Giannoni C, Pierpaoli L et al (2010) Chronic endurance exercise training prevents aging-related cognitive decline in healthy older adults: a randomized controlled trial. Int J Geriatr Psychiatry 25:1055-1064
19. Washburn RA, Smith KW, Jette AM et al (1993) The Physical Activity Scale for the Elderly (PASE): development and evaluation. J ClinEpidemiol 46:153-162 (Pubitemid 23092124)
20. Durnin JV, Womersley J (1974) Body fat assessed from total body density and its estimation from skinfold thickness: measurements on 481 men and women aged from 16 to 72 years. Br J Nutr 32:77-97
21. Diagnosis and classification of diabetes mellitus. Diabetes Care 2009 Gen 32 Suppl 1:S62-67
22. Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III). JAMA 2001 285:2486-97
23. Leite NC, Salles GF, Araujo ALE et al (2009) Prevalence and associated factors of non-alcoholic fatty liver disease in patients with type-2 diabetes mellitus. Liver Int Gen 29:113-119
24. Doi M, Miyoshi T, Hirohata S et al (2011) Association of increased plasma adipocyte fatty acid-binding protein with coronary artery disease in non-elderly men. Cardiovasc Diabetol 10:44
25. Kannel WB, D'Agostino RB, Silbershatz H (1997) Blood pressure and cardiovascular morbidity and mortality rates in the elderly. Am Heart J 134:758-763 (Pubitemid 27465073)
26. Cabré A, Lázaro I, Girona J et al (2008) Plasma fatty acid binding protein 4 is associated with atherogenic dyslipidemia in diabetes. J Lipid Res 49:1746-1751
27. Rhee EJ, Lee WY, Park CY et al (2009) The association of serum adipocyte fatty acid-binding protein with coronary artery disease in Korean adults. Eur J Endocrinol 160:165-172
28. Jin J, Peng D, Yuan S et al (2010) Serum adipocyte fatty acid binding proteins and adiponectin in patients with coronary artery disease: the significance of A-FABP/adiponectin ratio. Clin ChimActa 411(21-22):1761-1765
29. Hsu B-G, Chen Y-C, Lee R-P et al (2010) Fasting serum level of fatty-acid-binding protein 4 positively correlates with metabolic syndrome in patients with coronary artery disease. Circ J 74:327-331
30. Morley JE (2012) Undernutrition in older adults. Fam Pract 29(suppl 1):i89-i93